420 related articles for article (PubMed ID: 23777963)
1. [Secondary prevention with clopidogrel after TIA or stroke].
Zuurbier SM; Vermeer SE; Hilkens PH; Algra A; Roos YB
Ned Tijdschr Geneeskd; 2013; 157(25):A5836. PubMed ID: 23777963
[TBL] [Abstract][Full Text] [Related]
2. Acetylsalicylic acid + extended-release dipyridamole combination therapy for secondary stroke prevention.
Chaturvedi S
Clin Ther; 2008 Jul; 30(7):1196-205. PubMed ID: 18691981
[TBL] [Abstract][Full Text] [Related]
3. Combination antiplatelet agents for secondary prevention of ischemic stroke.
Vande Griend JP; Saseen JJ
Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
Niu PP; Guo ZN; Jin H; Xing YQ; Yang Y
BMJ Open; 2016 Mar; 6(3):e009013. PubMed ID: 26988347
[TBL] [Abstract][Full Text] [Related]
5. Secondary stroke prevention with antiplatelet therapy with emphasis on the cardiac patient: a neurologist's view.
Gebel JM
J Am Coll Cardiol; 2005 Sep; 46(5):752-5. PubMed ID: 16139120
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
Hankey GJ
Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
[TBL] [Abstract][Full Text] [Related]
7. Dual antiplatelet therapy with clopidogrel and aspirin after ischemic stroke: A review of the evidence.
Davis KA; Miyares MA; Dietrich E
Am J Health Syst Pharm; 2015 Oct; 72(19):1623-9. PubMed ID: 26386103
[TBL] [Abstract][Full Text] [Related]
8. [Secondary prevention with clopidogrel or acetylsalicylic acid after acute cerebrovascular event. Health services research study of private primary care specialists].
Sander D; Schwertfeger M; Köfüncü E; Diehm C; Pittrow D
Dtsch Med Wochenschr; 2008 Sep; 133(36):1773-8. PubMed ID: 18767003
[TBL] [Abstract][Full Text] [Related]
9. Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.
Greenhalgh J; Bagust A; Boland A; Martin Saborido C; Oyee J; Blundell M; Dundar Y; Dickson R; Proudlove C; Fisher M
Health Technol Assess; 2011 Sep; 15(31):1-178. PubMed ID: 21888837
[TBL] [Abstract][Full Text] [Related]
10. Prevention of ischaemic stroke--antiplatelets.
McCabe DJ; Brown MM
Br Med Bull; 2000; 56(2):510-25. PubMed ID: 11092100
[TBL] [Abstract][Full Text] [Related]
11. [Antithrombotic treatment as primary and secondary prevention of stroke].
Chukanova EI; Chukanova AS; Nadareyshvili GG; Gulieva MS
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(10):85-88. PubMed ID: 28635860
[TBL] [Abstract][Full Text] [Related]
12. Current strategies of secondary prevention after a cerebrovascular event: the Vienna stroke registry.
Lalouschek W; Lang W; Müllner M;
Stroke; 2001 Dec; 32(12):2860-6. PubMed ID: 11739988
[TBL] [Abstract][Full Text] [Related]
13. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
Kirshner HS
Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
[TBL] [Abstract][Full Text] [Related]
14. Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents.
Jamieson DG; Parekh A; Ezekowitz MD
J Cardiovasc Pharmacol Ther; 2005 Sep; 10(3):153-61. PubMed ID: 16211203
[TBL] [Abstract][Full Text] [Related]
15. Current guidelines on antiplatelet agents for secondary prevention of noncardiogenic stroke: an evidence-based review.
Simmons BB; Yeo A; Fung K; ;
Postgrad Med; 2010 Mar; 122(2):49-53. PubMed ID: 20203455
[TBL] [Abstract][Full Text] [Related]
16. Antiplatelets in secondary stroke prevention: should clopidogrel be the first choice?
Aw D; Sharma JC
Postgrad Med J; 2012 Jan; 88(1035):34-7. PubMed ID: 22121248
[TBL] [Abstract][Full Text] [Related]
17. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.
Tran H; Anand SS
JAMA; 2004 Oct; 292(15):1867-74. PubMed ID: 15494585
[TBL] [Abstract][Full Text] [Related]
18. Oral antiplatelet therapy in stroke prevention. Minireview.
Kral M; Herzig R; Sanak D; Skoloudik D; Vlachova I; Bartkova A; Hlustik P; Kovacik M; Kanovsky P
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2010 Sep; 154(3):203-10. PubMed ID: 21048805
[TBL] [Abstract][Full Text] [Related]
19. Aspirin plus clopidogrel as secondary prevention after stroke or transient ischemic attack: a systematic review and meta-analysis.
Zhang Q; Wang C; Zheng M; Li Y; Li J; Zhang L; Shang X; Yan C
Cerebrovasc Dis; 2015; 39(1):13-22. PubMed ID: 25547900
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
